0

531015

VENMAX

img img img img
No Data Available

VENMAX DRUGS AND PHARMACEUTICA Share Price Update

As of the latest trading session, VENMAX DRUGS AND PHARMACEUTICA is trading at ₹24.83, up by ₹0.94 or 3.93% from its previous close. The stock has moved between ₹23.00 and ₹24.96 today. Over the past year, the stock has delivered a return of -13.20%. In the last month, it has returned -9.60%.

Investment Returns

Over 1 Month -9.60% Over 3 Months -5.13% Over 6 Months -17.24% Over 1 Year -13.20%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VENMAX DRUGS AND PHARMACEUTICA fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 28.80
  • P/E Ratio (TTM) 113.76
  • Beta 0.48
  • Book Value / share 12.18
  • Return on equity 0.00%
  • EPS (TTM) 0.21
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.11
info icon alternate text

VENMAX DRUGS AND PHARMACEUTICA Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 3.94
Operating Expense 3.93
Net Profit 0.11
Net Profit Margin (%) 2.79
Earnings Per Share (EPS) 0.21
EBITDA 0.10
Effective Tax Rate (%) 0.00
Particulars DEC 2025 (Values in Cr)
Revenue 1.55
Operating Expense 1.58
Net Profit 0.03
Net Profit Margin (%) 1.93
Earnings Per Share (EPS) 0.05
EBITDA 0.04
Effective Tax Rate (%) 25.00
Particulars SEP 2025 (Values in Cr)
Revenue 1.32
Operating Expense 1.27
Net Profit 0.02
Net Profit Margin (%) 1.51
Earnings Per Share (EPS) 0.05
EBITDA 0.05
Effective Tax Rate (%) 40.00
Particulars JUN 2025 (Values in Cr)
Revenue 1.21
Operating Expense 1.17
Net Profit 0.04
Net Profit Margin (%) 3.30
Earnings Per Share (EPS) 0.07
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.33
Operating Expense 0.58
Net Profit 0.78
Net Profit Margin (%) 236.36
Earnings Per Share (EPS) 1.49
EBITDA 0.77
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 8.02
Operating Expense 7.91
Net Profit 0.25
Net Profit Margin (%) 3.11
Earnings Per Share (EPS) 0.21
EBITDA 0.28
Effective Tax Rate (%) 10.71
Particulars MAR 2025 (Values in Cr)
Revenue 0.81
Operating Expense 1.87
Net Profit -0.01
Net Profit Margin (%) -1.23
Earnings Per Share (EPS) -0.02
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit 0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.12
EBITDA 0.09
Effective Tax Rate (%) 22.22
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit 0.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.43
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.14
Net Profit 1.85
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 3.52
EBITDA 1.86
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share -1.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.11
EBITDA Margin 14.81
Particulars MAR 2024 (Values in Cr)
Book Value / Share -1.24
ROE % 1.15
ROCE % 1.43
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -1.36
ROE % 4.10
ROCE % 3.86
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -1.79
ROE % 116.35
ROCE % 63.14
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -5.32
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -88.24
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.48
Total Assets 5.16
Total Liabilities 5.16
Total Equity 4.41
Share Outstanding 0
Price to Book Ratio -22.63
Return on Assets (%) -0.20
Return on Capital (%) -0.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.08
Total Liabilities 0.08
Total Equity -0.65
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 79.23
Return on Capital (%) -21.64
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.71
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 106.71
Return on Capital (%) -62.25
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.21
Total Liabilities 0.21
Total Equity -0.94
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 864.37
Return on Capital (%) -312.35
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.07
Total Assets 0.30
Total Liabilities 0.30
Total Equity -2.78
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -52.82
Return on Capital (%) 35.53
Particulars MAR 2025 (Values in Cr)
Net Income -0.01
Cash from Operations -2.29
Cash from Investing 0.00
Cash from Financing 4.77
Net change in Cash 2.47
Free Cash Flow -2.29
Particulars MAR 2024 (Values in Cr)
Net Income 0.08
Cash from Operations 0.02
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.02
Particulars MAR 2023 (Values in Cr)
Net Income 0.22
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 1.84
Cash from Operations 1.90
Cash from Investing 0.00
Cash from Financing -1.98
Net change in Cash -0.07
Free Cash Flow 1.90
Particulars MAR 2021 (Values in Cr)
Net Income -0.16
Cash from Operations 0.26
Cash from Investing 0.00
Cash from Financing -0.18
Net change in Cash 0.07
Free Cash Flow 0.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.07 13.67 1.60 253.43 23.12 40.00
BLISS GVS PHARMA LTD. 300.20 24.29 2.66 3175.78 118.35 304.30
CIPLA LTD 1398.95 27.70 3.28 113007.26 1165.55 1672.20
FERMENTA BIOTECH LIMITED 302.65 10.07 2.27 890.73 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2309.80 38.33 17.25 39129.41 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.07 23.13 4.26 253.43 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 558.20 25.02 4.35 1613.79 490.00 789.95
ASTRAZENECA PHARMA IND LT 8604.25 103.40 26.92 21510.63 7630.00 10653.05
BLISS GVS PHARMA LTD. 300.20 32.28 2.74 3175.78 118.35 304.30

VENMAX DRUGS AND PHARMACEUTICA shareholding pattern

Holding
86.2%
13.79%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

VENMAX DRUGS AND PHARMACEUTICA Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
24.83 3.93 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 23.90
  • 26 Days 24.50
  • 10 Days 24.00
  • 50 Days 24.90
  • 12 Days 24.10
  • 100 Days 25.40
  • 20 Days 24.30
  • 200 Days 24.90
24.32 PIVOT
First Support 23.64 First Resistance 24.67 Second Support 23.29 Second Resistance 25.35 Third Support 22.61 Third Resistance 25.70
RSI 47.13 ADX 37.84 MACD -0.40 Williams % R -62.63 Commodity Channel Index (CCI) -3.58
Date 2026-05-22 Week 1738.00 Same Day 294.00 Month 1416.00
1 Year 0.50 3 Year 0.31
Over 1 Month
-9.60% down
Over 1 Year
-13.20% down
Over 3 Months
-5.13% down
Over 3 Years
0.00% down
Over 6 Months
-17.24% down
Over 5 Years
0.00% down

VENMAX DRUGS AND PHARMACEUTICA Corporate Actions

Top Gainers

Top Losers

VENMAX DRUGS AND PHARMACEUTICA Share Price

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998. The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995. It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'. Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009.

For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs). At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc.

The Company is developing the oncology products in R&D. Planning to establish a manufacturing UNIT with cGMP facility at Pharma Cluster at Hyderabad, to meet the export demand.

Parent organization Indian Private
NSE symbol [-]
Founded 1988
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

Venmax Drugs & Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 24.83 as on May 26 2026 03:08 PM.

What is the Market Cap of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Venmax Drugs & Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 28.80 as on May 26 2026 03:08 PM.

What is the 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 36.96 and ₹ 19.01.

What is 1 year return for Venmax Drugs & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -12.49%.

What is the P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on May 26 2026 03:08 PM the price-to-earnings (PE) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 113.76.

What is the PB ratio of Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

As on May 26 2026 03:08 PM, the price-to-book (PB) ratio for Venmax Drugs & Pharmaceuticals Ltd share is 12.18.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Venmax Drugs & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Venmax Drugs & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Venmax Drugs & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Venmax Drugs & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|